{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:35:32Z","timestamp":1779377732237,"version":"3.53.1"},"publisher-location":"Cham","reference-count":50,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031384363","type":"print"},{"value":"9783031384370","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/164_2023_660","type":"book-chapter","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T20:35:32Z","timestamp":1686688532000},"page":"249-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CaV3.2 (CACNA1H) in Primary Aldosteronism"],"prefix":"10.1007","author":[{"given":"Hoang An","family":"Dinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"St\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute I.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"660_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejphar.2008.02.001","volume":"584","author":"O Akizuki","year":"2008","unstructured":"Akizuki O, Inayoshi A, Kitayama T et al (2008) Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R. Eur J Pharmacol 584:424\u2013434. https:\/\/doi.org\/10.1016\/j.ejphar.2008.02.001","journal-title":"Eur J Pharmacol"},{"key":"660_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EAB Azizan","year":"2013","unstructured":"Azizan EAB, Poulsen H, Tuluc P et al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet 45:1055\u20131060. https:\/\/doi.org\/10.1038\/ng.2716","journal-title":"Nat Genet"},{"key":"660_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein F, Boulkroun S, Osswald A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45:440\u2013444. 444e1-2","journal-title":"Nat Genet"},{"key":"660_CR4","doi-asserted-by":"publisher","first-page":"13705","DOI":"10.1073\/pnas.1511740112","volume":"112","author":"I Blesneac","year":"2015","unstructured":"Blesneac I, Chemin J, Bidaud I et al (2015) Phosphorylation of the Cav3.2 T-type calcium channel directly regulates its gating properties. Proc Natl Acad Sci U S A 112:13705\u201313710","journal-title":"Proc Natl Acad Sci U S A"},{"key":"660_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/310501a0","volume":"310","author":"E Carbone","year":"1984","unstructured":"Carbone E, Lux HD (1984) A low voltage-activated, fully inactivating ca channel in vertebrate sensory neurones. Nature 310:501\u2013502. https:\/\/doi.org\/10.1038\/310501a0","journal-title":"Nature"},{"key":"660_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi M, Scholl UI, Yue P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768\u2013772","journal-title":"Science"},{"key":"660_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/07435809609043735","volume":"22","author":"CD Clyne","year":"1996","unstructured":"Clyne CD, White PC, Rainey WE (1996) Calcium regulates human CYP11B2 transcription. Endocr Res 22:485\u2013492","journal-title":"Endocr Res"},{"key":"660_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/01.RES.83.1.103","volume":"83","author":"LL Cribbs","year":"1998","unstructured":"Cribbs LL, Lee J-H, Yang J et al (1998) Cloning and characterization of \u03b11H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res 83:103\u2013109","journal-title":"Circ Res"},{"key":"660_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","volume":"13","author":"G Daniil","year":"2016","unstructured":"Daniil G, Fernandes-Rosa FL, Chemin J et al (2016) CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine 13:225\u2013236","journal-title":"EBioMedicine"},{"key":"660_CR10","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1530\/EJE-19-0377","volume":"181","author":"RK Dutta","year":"2019","unstructured":"Dutta RK, Arnesen T, Heie A et al (2019) A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma. Eur J Endocrinol 181:K37\u2013K41. https:\/\/doi.org\/10.1530\/EJE-19-0377","journal-title":"Eur J Endocrinol"},{"key":"660_CR11","doi-asserted-by":"crossref","unstructured":"Fernandes-Rosa FL, Daniil G, Orozco IJ et al (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 1","DOI":"10.1038\/s41588-018-0053-8"},{"key":"660_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1055\/s-0043-119802","volume":"49","author":"J Funder","year":"2017","unstructured":"Funder J (2017) Primary aldosteronism: the next five years. Horm Metab Res 49:977\u2013983. https:\/\/doi.org\/10.1055\/s-0043-119802","journal-title":"Horm Metab Res"},{"key":"660_CR50","doi-asserted-by":"publisher","unstructured":"Garcia-Caballero A, Zhang F-X, Hodgkinson V, Huang J, Chen L, Souza IA, Cain S, Kass J, Alles S, Snutch TP, Zamponi GW (2018) T-type calcium channels functionally interact with spectrin (\u03b1\/\u03b2) and ankyrin B. Mol Brain 11(1). https:\/\/doi.org\/10.1186\/s13041-018-0368-5","DOI":"10.1186\/s13041-018-0368-5"},{"key":"660_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15408-4","volume":"11","author":"NA Guagliardo","year":"2020","unstructured":"Guagliardo NA, Klein PM, Gancayco CA et al (2020) Angiotensin II induces coordinated calcium bursts in aldosterone-producing adrenal rosettes. Nat Commun 11:1\u201315","journal-title":"Nat Commun"},{"key":"660_CR14","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1172\/JCI61996","volume":"122","author":"C Hu","year":"2012","unstructured":"Hu C, Rusin CG, Tan Z et al (2012) Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Investig 122:2046\u20132053","journal-title":"J Clin Investig"},{"key":"660_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/01.fjc.0000197539.12685.f5","volume":"47","author":"K Imagawa","year":"2006","unstructured":"Imagawa K, Okayama S, Takaoka M et al (2006) Inhibitory effect of Efonidipine on aldosterone synthesis and secretion in human Adrenocarcinoma (H295R) cells. J Cardiovasc Pharmacol 47:133. https:\/\/doi.org\/10.1097\/01.fjc.0000197539.12685.f5","journal-title":"J Cardiovasc Pharmacol"},{"key":"660_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","volume":"75","author":"G Jaffe","year":"2020","unstructured":"Jaffe G, Gray Z, Krishnan G et al (2020) Screening rates for primary aldosteronism in resistant hypertension. Hypertension 75:650\u2013659. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14359","journal-title":"Hypertension"},{"key":"660_CR17","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1523\/JNEUROSCI.17-17-06621.1997","volume":"17","author":"RC Lambert","year":"1997","unstructured":"Lambert RC, Maulet Y, Mouton J et al (1997) T-type Ca2+ current properties are not modified by Ca2+ channel \u03b2 subunit depletion in Nodosus ganglion neurons. J Neurosci 17:6621\u20136628. https:\/\/doi.org\/10.1523\/JNEUROSCI.17-17-06621.1997","journal-title":"J Neurosci"},{"key":"660_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric ll\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265. https:\/\/doi.org\/10.1038\/355262a0","journal-title":"Nature"},{"key":"660_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","volume":"75","author":"K Nanba","year":"2020","unstructured":"Nanba K, Blinder AR, Rege J et al (2020) Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma. Hypertension 75:645\u2013649. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14349","journal-title":"Hypertension"},{"key":"660_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fphys.2014.00209","volume":"5","author":"A Neely","year":"2014","unstructured":"Neely A, Hidalgo P (2014) Structure-function of proteins interacting with the \u03b11 pore-forming subunit of high-voltage-activated calcium channels. Front Physiol 5:209","journal-title":"Front Physiol"},{"key":"660_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/316443a0","volume":"316","author":"B Nilius","year":"1985","unstructured":"Nilius B, Hess P, Lansman JB, Tsien RW (1985) A novel type of cardiac calcium channel in ventricular cells. Nature 316:443\u2013446. https:\/\/doi.org\/10.1038\/316443a0","journal-title":"Nature"},{"key":"660_CR22","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto K, Tomlins SA, Kuick R et al (2015) Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S A 112:E4591\u2013E4599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"660_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata K, Satoh F, Morimoto R et al (2018) Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72:874\u2013880. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11086","journal-title":"Hypertension"},{"key":"660_CR24","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1210\/en.2012-1527","volume":"153","author":"D Penton","year":"2012","unstructured":"Penton D, Bandulik S, Schweda F et al (2012) Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. Endocrinology 153:4740\u20134748. https:\/\/doi.org\/10.1210\/en.2012-1527","journal-title":"Endocrinology"},{"key":"660_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/36110","volume":"391","author":"E Perez-Reyes","year":"1998","unstructured":"Perez-Reyes E, Cribbs LL, Daud A et al (1998) Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 391:896\u2013900. https:\/\/doi.org\/10.1038\/36110","journal-title":"Nature"},{"key":"660_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1067\/mcp.2001.113406","volume":"69","author":"I Ragueneau","year":"2001","unstructured":"Ragueneau I, Sao AB, D\u00e9molis J-L et al (2001) Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers. Clin Pharmacol Ther 69:122\u2013129. https:\/\/doi.org\/10.1067\/mcp.2001.113406","journal-title":"Clin Pharmacol Ther"},{"key":"660_CR27","doi-asserted-by":"publisher","unstructured":"Rege J, Nanba K, Bandulik S et al (2022) Zinc transporter somatic gene mutations cause primary aldosteronism. https:\/\/doi.org\/10.1101\/2022.07.25.501443","DOI":"10.1101\/2022.07.25.501443"},{"key":"660_CR28","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1210\/en.2016-1170","volume":"157","author":"EN Reimer","year":"2016","unstructured":"Reimer EN, Walenda G, Seidel E, Scholl UI (2016) CACNA1HM1549V mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by Mibefradil. Endocrinology 157:3016\u20133022. https:\/\/doi.org\/10.1210\/en.2016-1170","journal-title":"Endocrinology"},{"key":"660_CR29","first-page":"824","volume":"287","author":"MF Rossier","year":"1998","unstructured":"Rossier MF, Ertel EA, Vallotton MB, Capponi AM (1998) Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J Pharmacol Exp Ther 287:824\u2013831","journal-title":"J Pharmacol Exp Ther"},{"key":"660_CR30","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/s41467-019-13033-4","volume":"10","author":"J Schewe","year":"2019","unstructured":"Schewe J, Seidel E, Forslund S et al (2019) Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation. Nat Commun 10:5155","journal-title":"Nat Commun"},{"key":"660_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/clpt.1992.147","volume":"52","author":"R Schmitt","year":"1992","unstructured":"Schmitt R, Kleinbloesem CH, Belz GG et al (1992) Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension. Clin Pharmacol Ther 52:314\u2013323. https:\/\/doi.org\/10.1038\/clpt.1992.147","journal-title":"Clin Pharmacol Ther"},{"key":"660_CR32","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl UI, Goh G, St\u00f6lting G et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050\u20131054","journal-title":"Nat Genet"},{"key":"660_CR33","doi-asserted-by":"publisher","first-page":"e06315","DOI":"10.7554\/eLife.06315","volume":"4","author":"UI Scholl","year":"2015","unstructured":"Scholl UI, St\u00f6lting G, Nelson-Williams C et al (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. eLife Sci 4:e06315","journal-title":"eLife Sci"},{"key":"660_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl UI, St\u00f6lting G, Schewe J et al (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349\u2013354","journal-title":"Nat Genet"},{"key":"660_CR35","doi-asserted-by":"crossref","unstructured":"Seidel E, Schewe J, Zhang J et al (2021) Enhanced Ca2+ signaling, mild primary aldosteronism, and hypertension in a familial hyperaldosteronism mouse model (Cacna1hM1560V\/+). Proc Natl Acad Sci U S A 118","DOI":"10.1073\/pnas.2014876118"},{"key":"660_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02155834","volume":"9","author":"SA Simpson","year":"1953","unstructured":"Simpson SA, Tait JF, Wettstein A et al (1953) Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel. Experientia 9:333\u2013335","journal-title":"Experientia"},{"key":"660_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","volume":"84","author":"A Sp\u00e4t","year":"2004","unstructured":"Sp\u00e4t A, Hunyady L (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489\u2013539. https:\/\/doi.org\/10.1152\/physrev.00030.2003","journal-title":"Physiol Rev"},{"key":"660_CR38","doi-asserted-by":"publisher","first-page":"F254","DOI":"10.1152\/ajprenal.00121.2018","volume":"317","author":"AD Thuesen","year":"2019","unstructured":"Thuesen AD, Finsen SH, Rasmussen LL et al (2019) Deficiency of T-type ca 2+ channels ca v 3.1 and ca v 3.2 has no effect on angiotensin II-induced hypertension but differential effect on plasma aldosterone in mice. Am J Physiol Renal Physiol 317:F254\u2013F263","journal-title":"Am J Physiol Renal Physiol"},{"key":"660_CR39","doi-asserted-by":"crossref","unstructured":"Tseng C-S, Peng K-Y, Wang S-M et al (2022) A novel somatic mutation of CACNA1H p.V1937M in unilateral primary hyperaldosteronism. Front Endocrinol 13","DOI":"10.3389\/fendo.2022.816476"},{"key":"660_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0896-6273(94)90363-8","volume":"13","author":"MD Waard","year":"1994","unstructured":"Waard MD, Pragnell M, Campbell KP (1994) Ca2+ channel regulation by a conserved \u03b2 subunit domain. Neuron 13:495\u2013503. https:\/\/doi.org\/10.1016\/0896-6273(94)90363-8","journal-title":"Neuron"},{"key":"660_CR41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00424-013-1259-3","volume":"465","author":"N Weiss","year":"2013","unstructured":"Weiss N, Black SAG, Bladen C et al (2013) Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation. Pflugers Arch Eur J Physiol 465:1159\u20131170. https:\/\/doi.org\/10.1007\/s00424-013-1259-3","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"660_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"Williams TA, Gomez-Sanchez CE, Rainey WE et al (2021) International histopathology consensus for unilateral primary aldosteronism. J Clin Endocrinol Metabol 106:42\u201354. https:\/\/doi.org\/10.1210\/clinem\/dgaa484","journal-title":"J Clin Endocrinol Metabol"},{"key":"660_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature01772","volume":"424","author":"JT Wolfe","year":"2003","unstructured":"Wolfe JT, Wang H, Howard J et al (2003) T-type calcium channel regulation by specific G-protein \u03b2\u03b3 subunits. Nature 424:209\u2013213","journal-title":"Nature"},{"key":"660_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/biomedicines9091167","volume":"9","author":"C-H Wu","year":"2021","unstructured":"Wu C-H, Peng K-Y, Hwang D-Y et al (2021) Novel mutations detection with next-generation sequencing and its association with clinical outcome in unilateral primary aldosteronism. Biomedicine 9:1167. https:\/\/doi.org\/10.3390\/biomedicines9091167","journal-title":"Biomedicine"},{"key":"660_CR45","doi-asserted-by":"publisher","first-page":"OR34-02","DOI":"10.1210\/jendso\/bvaa046.492","volume":"4","author":"X Wu","year":"2020","unstructured":"Wu X, Garg S, Cabrera CP et al (2020) OR34-02 somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells. J Endocrine Soc 4:OR34-02. https:\/\/doi.org\/10.1210\/jendso\/bvaa046.492","journal-title":"J Endocrine Soc"},{"key":"660_CR46","doi-asserted-by":"publisher","first-page":"e229031","DOI":"10.1136\/bcr-2018-229031","volume":"12","author":"K Wulczyn","year":"2019","unstructured":"Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M (2019) Primary aldosteronism associated with a germline variant in CACNA1H. BMJ Case Rep CP 12:e229031. https:\/\/doi.org\/10.1136\/bcr-2018-229031","journal-title":"BMJ Case Rep CP"},{"key":"660_CR47","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/endo.137.10.8828493","volume":"137","author":"A Yagci","year":"1996","unstructured":"Yagci A, M\u00fcller J (1996) Induction of steroidogenic enzymes by potassium in cultured rat zona glomerulosa cells depends on calcium influx and intact protein synthesis. Endocrinology 137:4331\u20134338. https:\/\/doi.org\/10.1210\/endo.137.10.8828493","journal-title":"Endocrinology"},{"key":"660_CR48","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/hmg\/ddl068","volume":"15","author":"X Zhong","year":"2006","unstructured":"Zhong X, Liu JR, Kyle JW et al (2006) A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum Mol Genet 15:1497\u20131512. https:\/\/doi.org\/10.1093\/hmg\/ddl068","journal-title":"Hum Mol Genet"},{"key":"660_CR49","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","volume":"53","author":"J Zhou","year":"2021","unstructured":"Zhou J, Azizan EAB, Cabrera CP et al (2021) Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat Genet 53:1360\u20131372","journal-title":"Nat Genet"}],"container-title":["Handbook of Experimental Pharmacology","Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2023_660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T22:44:59Z","timestamp":1690843499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2023_660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031384363","9783031384370"],"references-count":50,"URL":"https:\/\/doi.org\/10.1007\/164_2023_660","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"14 June 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}